stockrowBausch + Lomb Corporation
BLCO Healthcare Medical Instruments & Supplies
Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.
- Revenue
- +7.34%
- EPS
- +222.4%
- Free cash flow
- +182.5%
- Total debt
- +2.93%
Quarter to September 2026, against a year earlier
Follow BLCO
Alert me
Bausch + Lomb Corporation (BLCO) EBITDA
Bausch + Lomb Corporation's EBITDA for fiscal 2025 was $552.0M, down 10.7% from $618.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $801.0M. Over the past ten years it has ranged from $542.0M (fiscal 2023) to $744.0M (fiscal 2021); the current reading is higher than 33% of that period. Bausch + Lomb Corporation ranks 12th of 47 Medical Instruments & Supplies companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $552.0M | (10.68%) |
| FY2024 | $618.0M | 14.02% |
| FY2023 | $542.0M | (8.75%) |
| FY2022 | $594.0M | (20.16%) |
| FY2021 | $744.0M | 5.98% |
| FY2020 | $702.0M | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $260.0M | 37.57% |
| Jun 2026 | $189.0M | 37.96% |
| Mar 2026 | $137.0M | (36.28%) |
| Dec 2025 | $215.0M | 3.37% |
| 19 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| COO The Cooper Companies, Inc. compare | $928.2M |
| AVTR Avantor, Inc. compare | $913.6M |
| ALGN Align Technology, Inc. compare | $802.0M |
| BLCO Bausch + Lomb Corporation | $801.0M |
| ATR AptarGroup, Inc. compare | $783.0M |
| MMSI Merit Medical Systems, Inc. compare | $359.6M |
| TFX Teleflex Incorporated compare | $256.2M |
| RGEN Repligen Corporation compare | $155.0M |
| MMED MiniMed Group, Inc. compare | −$8.0M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on BLCO
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement